Apoptosis - Death deceiver

被引:53
作者
Green, DR [1 ]
机构
[1] La Jolla Inst Allergy & Immunol, San Diego, CA 92121 USA
关键词
D O I
10.1038/25248
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Tumours develop because the tumour cells are immortal -- they escape cell-killing mechanisms. Normally, when a molecule called Fas binds its ligand (FasL), a death pathway (apoptosis) is activated. But another molecule called DcR3, which has now been identified in lung and colon carcinomas, can also bind FasL, blocking the apoptotic pathway and allowing tumour cells to cheat death.
引用
收藏
页码:629 / 630
页数:2
相关论文
共 10 条
  • [1] Inducible nonlymphoid expression of Fas ligand is responsible for superantigen-induced peripheral deletion of T cells
    Bonfoco, E
    Stuart, PM
    Brunner, T
    Lin, T
    Griffith, TS
    Gao, Y
    Nakajima, H
    Henkart, PA
    Ferguson, TA
    Green, DR
    [J]. IMMUNITY, 1998, 9 (05) : 711 - 720
  • [2] Involvement of the CD95 (APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells
    Friesen, C
    Herr, I
    Krammer, PH
    Debatin, KM
    [J]. NATURE MEDICINE, 1996, 2 (05) : 574 - 577
  • [3] Apoptotic pathways: The roads to ruin
    Green, DR
    [J]. CELL, 1998, 94 (06) : 695 - 698
  • [4] Thymineless death in colon carcinoma cells is mediated via Fas signaling
    Houghton, JA
    Harwood, FG
    Tillman, DM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (15) : 8144 - 8149
  • [5] Requirement for the CD95 receptor-ligand pathway in c-myc-induced apoptosis
    Hueber, AO
    Zornig, M
    Lyon, D
    Suda, T
    Nagata, S
    Evan, GI
    [J]. SCIENCE, 1997, 278 (5341) : 1305 - 1309
  • [6] Midis GP, 1996, CANCER RES, V56, P3870
  • [7] Fas and fas ligand interactions suppress melanoma lung metastasis
    Owen-Schaub, LB
    van Golen, KL
    Hill, LL
    Price, JE
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (09) : 1717 - 1723
  • [8] Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer
    Pitti, RM
    Marsters, SA
    Lawrence, DA
    Roy, M
    Kischkel, FC
    Dowd, P
    Huang, A
    Donahue, CJ
    Sherwood, SW
    Baldwin, DT
    Godowski, PJ
    Wood, WI
    Gurney, AL
    Hillan, KJ
    Cohen, RL
    Goddard, AD
    Botstein, D
    Ashkenazi, A
    [J]. NATURE, 1998, 396 (6712) : 699 - 703
  • [9] Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand
    Suzuki, I
    Fink, PJ
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (01) : 123 - 128
  • [10] ZORNIG M, 1995, ONCOGENE, V10, P2397